Extensively Drug Resistance Process

Known as: EXTENSIVE DRUG RESISTANCE, XDR 
Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Drug Resistance Status TerminologyClinical Data Interchange Standards Consortium TerminologyPharmacologic Substance

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.
Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis remains out of control in several… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2017
Review
2017
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.
Acinetobacter is a complex genus, and historically, there has been confusion about the existence of multiple species. The species… (More)
Is this relevant?
Review
2017
Review
2017
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.
BACKGROUND Drug-resistant tuberculosis threatens recent gains in the treatment of tuberculosis and human immunodeficiency virus… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.
A meta-analysis for response to treatment was undertaken using individual data of multidrug-resistant tuberculosis (MDR-TB… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
Many different definitions for multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) bacteria… (More)
  • table 1
  • table 2
  • table 3
  • table 3
  • table 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
BACKGROUND Linezolid has antimycobacterial activity in vitro and is increasingly used for patients with highly drug-resistant… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2009
Review
2009
Mechanisms of drug resistance in Mycobacterium tuberculosis.
The increasing emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in the era of human… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
The rise of multi-drug resistant (MDR) and extensively drug resistant (XDR) tuberculosis around the world, including in… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
BACKGROUND The epidemics of HIV-1 and tuberculosis in South Africa are closely related. High mortality rates in co-infected… (More)
  • table 1
  • table 2
Is this relevant?